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Abstract 
Background: Only about half of people with obsessive compulsive disorder (OCD) show 
clinically significant improvement following the recommended therapy, exposure and 
response prevention (ERP), partly due to poor therapy acceptability. A mindfulness-based 
approach to ERP (MB-ERP) has the potential to improve acceptability and outcomes.  
Methods: This was an internal pilot randomised controlled trial (RCT) of group MB-ERP 
compared to group ERP. 37 participants meeting DSM-IV OCD criteria were randomly 
allocated to MB-ERP or ERP.  
Results: Both groups improved in OCD symptom severity. However, MB-ERP did not lead 
to clinically important improvements in OCD symptom severity at post-intervention 
compared to ERP – the minimum clinically important difference was not contained in the 
95% confidence intervals. There were negligible between-group differences in engagement 
and MB-ERP did not appear to have broader benefits compared to ERP on depression, 
wellbeing or OCD-related beliefs. Conversely, MB-ERP led to medium/medium-large 
improvements in mindfulness compared to ERP. 
Conclusions: MB-ERP is unlikely to lead to clinically meaningful improvements in OCD 
symptom severity compared to ERP alone. We underline the importance of adhering to 
treatment guidelines recommending ERP for OCD. Insufficient attention may have been 
given to mindfulness practice/discussion in MB-ERP and further research is recommended to 
explore this possibility.  
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Highlights 
 
• Only 50% of people OCD recover after exposure and response prevention (ERP) 
• Mindfulness-based ERP has potential to improve acceptability and outcomes 
• Our pilot RCT showed MB-ERP is unlikely to improve outcomes compared to ERP alone 
• On average 6.5/10 sessions were attended with little difference between therapy arms 
• Findings underline the need to be cautious in offering therapies ahead of evidence 
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1. Introduction 
Obsessive compulsive disorder (OCD) is characterised by persistent intrusive thoughts 
that cause significant anxiety and repetitive behaviours aimed at neutralising anxiety or 
preventing a dreaded event (American Psychiatric Association, 2013). OCD has a lifetime 
prevalence of 0.7-2.5 percent (Crino, Slade, & Andrews, 2005) and is associated with poor 
quality of life (Macy et al., 2013). 
Practice guidelines recommend exposure and response prevention (ERP), delivered 
with or without cognitive therapy, as the psychological therapy for OCD (American 
Psychiatric Association, 2007; National Institute of Health and Care Excellence [NICE], 
2005). Whilst ERP is effective for OCD, around 50% of people do not recover after therapy 
(Öst, Havnen, Hansen, & Kvale, 2015).  
Exposure-based therapies are theorised to work through habituation to the obsession 
(Ponniah, Magiati, & Hollon, 2013) and/or through inhibitory learning, i.e. strengthening 
competing non-fear memories about the feared object/event (Craske, Treanor, Conway, 
Zbozinek, & Vervliet, 2014). Frequent, repeated exposure tasks are required for both these 
processes to occur, with inhibitory learning theory emphasising the context-specific nature of 
new learning (Craske et al., 2014). Recovery is therefore unlikely in the absence of frequent, 
repeated ERP tasks performed in various contexts. By definition ERP is anxiety-provoking 
and yet, people with OCD can be particularly intolerant of anxiety (Cougle, Timpano, Fitch, 
& Hawkins, 2011; Olatunji, Deacon, & Abramowitz, 2009). It has been suggested that poor 
engagement with ERP might explain disappointing recovery rates. Indeed, a naturalistic study 
found that 25% of adults with OCD refused CBT despite professional recommendation 
(Mancebo, Eisen, Sibrava, Dyck, & Rasmussen, 2011) whilst Ost et al. (2015) reported a 
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19.1% dropout rate for ERP. Even when people complete a course of ERP, task engagement 
may be insufficient to achieve recovery. For example, Simpson et al. (2011) found that 
adherence to between-session ERP tasks significantly predicted treatment outcome and that 
adherence had to be high (75-90% of all ERP task assignments) to achieve a clinically 
significant change in OCD symptoms.  
Enhancing the acceptability of ERP might increase engagement and thereby improve 
outcomes. Mindfulness can be defined as “paying attention in a particular way: on purpose, in 
the present moment, and nonjudgmentally” (Kabat-Zinn, 1994) (p. 4). It can be cultivated 
through mindfulness practice to increase non-judgemental awareness and skills in responding 
to thoughts and feelings (Bishop, 2004). Mindfulness-based interventions (MBIs) have 
demonstrated positive outcomes for clinical populations with a broad range of mental health 
difficulties (Khoury et al., 2013; Kuyken et al., 2016; Strauss, Cavanagh, Oliver, & Pettman, 
2014). Preliminary evidence suggests that MBIs could also benefit OCD (Hale, Strauss, & 
Taylor, 2013; Key, Rowa, Bieling, McCabe, & Pawluk, 2017). Metacognitive Therapy is an 
approach with some theoretical and therapeutic similarities to MBIs (Wells, 1997). In the 
treatment of OCD, metacognitive beliefs about intrusive thoughts are identified and 
reappraised and what is termed ‘detached mindfulness’ exercises are practiced. This involves 
noticing intrusive thoughts and allowing them to naturally pass without engaging with them. 
Preliminary research on Metacognitive Therapy for OCD suggests it can lead to clinically 
important changes in symptom severity (Fisher & Wells, 2008). Whilst MBIs and related 
approaches has potential in the treatment of OCD there is a risk that the benefits of ERP are 
lost in these novel approaches. Given the strength of evidence for ERP (Öst et al., 2015), we 
suggest combining an MBI with ERP has the greatest potential to provide benefit.   
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The present study proposes that a mindfulness-based approach to ERP (MB-ERP) could 
enhance engagement in ERP and improve outcomes for three reasons. First, through 
mindfulness practice and discussion, MBIs invite and support people to allow thoughts into 
awareness with acceptance, and without judging or attempting to suppress them (Segal, 
Williams, & Teasdale, 2013). Whilst traditional ERP involves exposure to intrusive thoughts 
as a core part of the therapy, strategies to facilitate exposure to intrusive thoughts are not well 
established and may in part explain poor rates of ERP task engagement. We suggest that 
guided mindfulness practice could enable people to fully exposure to intrusive thoughts. In-
the-moment verbal guidance is given during mindfulness practice in session and between-
session mindfulness practice is supported through the use of audio recordings. The verbal 
guidance encourages noticing and sitting with difficult thoughts as they arise with curiosity 
and acceptance. Therefore MB-ERP could enable people to expose to and accept intrusive 
thoughts and to remain engaged in ERP tasks despite such thoughts. Second, people with 
OCD have a heightened intolerance of anxiety (Cougle et al., 2011). This is particularly 
problematic for ERP which by definition is an anxiety-provoking intervention. Whilst 
traditional ERP encourages people to stay with feelings of anxiety during tasks as a core part 
of the intervention, strategies that enable people to do this are not well understood and may 
well explain poor rates of engagement with ERP tasks. We suggest that a mindfulness-based 
approach could provide a means to cultivate the ability to sit with high levels of anxious 
arousal. Guided mindfulness practice invites people to carefully observe and accept 
unpleasant physical sensations of anxiety with a sense of kindness and curiosity, and in-the-
moment verbal guidance may be particularly important when cultivating this ability in the 
face of present-moment anxiety (Segal et al., 2013). Therefore, MB-ERP could provide a 
means through which people are better able to attend to and accept these sensations during 
ERP tasks and nevertheless, sustain task engagement. Third, MBIs encourage people to be 
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aware of behavioural choices available in response to an event, rather than reacting 
automatically (Segal et al., 2013).Guidance offered during mindfulness practice draws 
attention to in-the-moment behavioural choices that may otherwise go unnoticed. We suggest 
that this may help to cultivate the ability to notice and choose how best to respond to 
compulsive urges rather than reacting to them automatically. MB-ERP could therefore help 
people to consciously choose to resist urges to engage in compulsions during ERP tasks.  
In line with MRC guidance in the UK on the sequential phases of development of RCTs 
for complex interventions (Medical Research Council, 1998) and from the National Institute 
for Health Research in the UK (National Institute for Health Research, 2017), this study was 
an internal pilot RCT conducted in anticipation of a definitive trial that examines whether 
group MB-ERP is more effective at reducing OCD symptom severity and better at enhancing 
therapy engagement than standard group ERP for people with OCD. An internal pilot RCT is 
a smaller version of a fully powered definitive trial that is run prior to the definitive trial to 
check trial procedures are running smoothly and to estimate the sample size required for the 
definitive trial, and indeed to determine if a definitive trial is warranted (National Institute for 
Health Research, 2017). The primary aim of this internal pilot study was to estimate the size 
and direction of the potential treatment effect, and the corresponding 95% confidence 
interval, by comparing MB-ERP groups to standard ERP groups on the primary outcome 
measures of OCD symptom severity and therapy engagement. Measures of other outcome 
(depression and wellbeing) and process (mindfulness and obsessive-compulsive beliefs) were 
included. 
A definitive trial of the same study design was planned if the direction of potential 
treatment effect was in favour of MB-ERP over ERP. Hypotheses for the definitive trial 
would be that MB-ERP in comparison to ERP would lead to greater improvements in OCD 
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symptom severity at post-intervention (primary hypothesis), and that this would be mediated 
by greater engagement with ERP tasks. Greater improvements in depression symptom 
severity and wellbeing (secondary hypotheses) and greater improvements in mindfulness and 
obsessive-compulsive beliefs (process hypotheses) for MB-ERP in comparison to ERP would 
also be hypothesised.   
2. Material Method 
2.1 Design and sample size  
  This is an internal pilot for a pragmatic single centre, assessor-blind, superiority RCT, 
with two parallel-groups and 1:1 allocation to either MB-ERP or ERP alone. The trial was 
registered prior to recruitment commencing (ISRCTN52684820. Registered on 30 January 
2014) and the therapy protocol was published prior to recruitment ending ([author names 
removed to preserve anonymity]). This study received ethical approval through the South 
East Coast (Surrey) arm of the National Research Ethics System in the UK (reference: 
13/LO/1768). Recruitment occurred between March 2014 and January 2015. 
2.2 Participants 
 Inclusion criteria were that participants: (1) met DSM-IV (American Psychiatric 
Association, 2013) diagnostic criteria for OCD based on the Mini International 
Neuropsychiatric Interview [MINI 6.0.0] (Sheehan et al., 2010); (2) were stable on 
psychiatric medication for at least 3 months prior to consent; (3) had no plans for changing 
psychiatric medication during the study; (4) had not received psychological therapy in the 
past three months and had no plans for commencing therapy during the study; and (5) were 
18 years or older. It should be noted that the DSM-IV version of the MINI (6.0.0) was used 
as the DSM-5 version (MINI 7.0.0) was not available at the time of recruitment.  
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 People were excluded if they had an identified organic cause for their OCD 
symptoms, a diagnosed learning disability, or met DSM-IV diagnostic criteria for a psychotic 
disorder, post-traumatic stress disorder (PTSD), anorexia nervosa, alcohol abuse or substance 
abuse based on MINI 6.0.0 interview (Sheehan et al., 2010). Psychosis, anorexia and PTSD 
were exclusion criteria because of concerns that mindfulness practice can heighten distress or 
exacerbate symptoms in the face of psychotic experiences, bodily sensations and cognitions 
associated with anorexia and in the face of intrusive traumatic memories. Research exploring 
the safety of MBIs in these populations is limited and as such they were added as exclusion 
criteria.  People with hoarding-only compulsions were excluded as this is no longer 
considered a subtype of OCD (American Psychiatric Association, 2013). 
2.3 Procedure 
 Recruitment occurred in two sites within an NHS Mental Health Trust in the South 
of the England. The research assistant completed baseline assessments within four weeks of 
the therapy groups starting. Following the baseline assessment, participants were randomly 
allocated to an MB-ERP or an ERP group. Measures were taken at baseline (Time 1), post-
therapy (Time 2) and at 6-months post-therapy (Time 3). 
2.4. Interventions 
 Further details of the intervention protocols are in the published protocol ([author 
names removed to preserve anonymity]). To minimise therapist effects all therapy sessions 
(MB-ERP and ERP) were facilitated by the same two clinical psychologists, one of whom 
was an accredited Cognitive Behavioural Therapy (CBT) therapist and accredited MBCT 
teacher. Supervision was provided for both group facilitators by an expert in ERP. 
Mindfulness supervision was provided by an accredited MBCT supervisor 
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2.4.1 ERP groups 
 The ERP group consisted of 10 two-hour sessions based on treatment 
recommendations derived from inhibitory learning theory (Abramowitz & Arch, 2014; Arch 
& Abramowitz, 2015). Session 1 introduced the rationale for ERP. Sessions 2 to 9 involved 
participants designing in-vivo and between-session ERP tasks. Participants were strongly 
encouraged to engage in their planned ERP tasks at least daily between group sessions and to 
use their ERP daily diaries to monitor engagement with tasks. Participants were also 
encouraged to conduct unplanned ERP tasks in daily life when facing obsessional cues. 
Session 10 focused on consolidating learning. If a participant missed a session they were 
contacted by phone by one of the group facilitators immediately after the session to explore 
reasons for missing the session and to identify and plan daily ERP tasks. 
2.4.2 MB-ERP groups 
 The MB-ERP group consisted of 10 two-hour sessions. Session 1 introduced the 
rationale for ERP alongside the rationale for including mindfulness. Sessions 2 to 9 each 
began with a 10-minute guided mindfulness practice: mindfulness of the breath and body 
(session 1); mindfulness of the breath, body, sounds and (intrusive) thoughts (sessions 2-3); 
mindfulness of (intrusive) thoughts (session 4-5); and mindfulness of body, (intrusive) 
thoughts, urges and action (sessions 6-10). Verbal guidance for the mindfulness practice was 
developed particularly for this study by an expert in MBIs and OCD, focusing on the three 
mechanisms outlined earlier: (1) mindfulness of intrusive thoughts, (2) mindfulness of body 
sensations of anxiety, and (3) mindfulness of compulsive urges. The guidance differed to that 
found in MBCT and other related approaches. The verbal guidance explicitly invited people 
to notice intrusive thoughts, bodily sensations associated with intrusive thoughts/anxiety and 
compulsive urges and to bring a sense of acceptance to these experiences. Mindfulness 
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practices were followed by a 20-minute Socratic inquiry. A three-minute mindfulness 
breathing space practice (Segal, Williams, & Teasdale, 2002) was also introduced from 
session 6 onwards. The final 90 minutes of MB-ERP session followed the same ERP protocol 
outlined above. During ERP tasks, participants were encouraged to bring mindfulness to the 
tasks. Session 10 focused on consolidating learning from the therapy. If a participant missed a 
session they were contacted by phone by one of the group facilitators immediately after the 
session to explore reasons for missing the session, to identify and plan daily ERP tasks and to 
support continued home mindfulness practice. 
2.5 Outcome Measures 
2.5.1 Therapy Fidelity 
 Therapy sessions were audio recorded and three randomly selected sessions from 
each group in each site were rated for fidelity to the relevant protocol (MB-ERP or ERP) by 
an OCD expert. Each element of the therapy protocol was scored on a 0-2 scale (0=element 
not present; 1=element partially present; 2=element fully present) and total percentage 
fidelity calculated.  
2.5.2 Diagnostic status 
 The Mini International Neuropsychiatric Interview (MINI version 6.0.0) (Sheehan et 
al., 2010). DSM-IV OCD diagnosis was established at all time points using the OCD section 
of the MINI 6.0.0. At baseline, in order to determine possible reasons for exclusion, the MINI 
6.0.0 was also administered for psychotic disorder, post-traumatic stress disorder, anorexia 
nervosa, alcohol abuse or substance abuse. 
2.5.3 Primary outcome measures 
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 Yale-Brown Obsessive Compulsive Scale - Second Edition (YBOCS-II) (Goodman, 
Rasmussen, Price, & Storch, 2006). The YBOCS-II is a measure of OCD symptom severity 
and has excellent indices of reliability and validity (Storch, et al., 2010). The overall score for 
YBOCS-II varies between 0-50 with ten items, each rated on a 0-5 scale, with higher scores 
indicating greater OCD symptom severity. A minimum clinically important difference 
(MCID) of 5 would represent an average difference of 0.5 per item. This was determined 
through consultation with the Lived Experience Advisory Panel (LEAP) for the study who 
provided consultation during the development and implementation of the trial. The LEAP 
suggested that an average improvement of half a point per item on the YBOCS-II would 
constitute a meaningful level of improvement.  
 ERP engagement. Engagement was measured as: (1) the number of therapy sessions 
attended (0-10), and (2) the number of ERP tasks performed between sessions. Participants 
were given daily diaries to record ERP home tasks.  
2.5.4 Secondary outcome measures 
 Short Warwick-Edinburgh Mental Well-Being Scale (Stewart-Brown et al., 2009). 
This is a 7-item measure of well-being with items rated on a 5-point scale (items rated 1-5). A 
higher score indicates greater wellbeing. Stewart-Brown and colleagues (2011) reported 
strong internal consistency, test re-test reliability, and concurrent validity and found that the 
measure is sensitive to change in mental health populations. 
 Beck Depression Inventory - second edition (BDI-II) (Beck, Steer, & Brown, 1996). 
The BDI-II is a 21-item measure of depressive symptom severity with items rated on a 4-
point (0-3) scale. Higher scores indicate greater depressive symptom severity. It has excellent 
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internal consistency and test re-test reliability (α >0.9 for both). Concurrent validity with the 
Hamilton Psychiatric Rating Scale for Depression-Revised is good (r = 0.71). 
 Five-Facet Mindfulness Questionnaire - Short Form (FFMQ-SF) (Baer, Smith, 
Hopkins, Krietemeyer, & Toney, 2006; Bohlmeijer, ten Klooster, Fledderus, Veehof, & Baer, 
2011). The FFMQ-SF is a 24-item self-report scale assessing five mindfulness factors: 
observing, describing, acting with awareness, non-judgement and non-reacting. Items are 
rated on a 5-point (1-5) scale and higher subscale/scale totals indicate greater levels of 
mindfulness. The short form has adequate indices of reliability (α > .73 for each subscale) 
and validity (Bohlmeijer et al., 2011). 
 Obsessional Beliefs Questionnaire - Revised (OBQ-44) (Obsessive Compulsive 
Cognitions Working Group, 2005). The OBQ-44 is a 44-item self-report measure of OCD-
related cognitions with items rated on a 7-point (1-7 scale). Higher scores indicate greater 
endorsement of problematic OCD-related cognitions. The instrument has three subscales: (1) 
Responsibility/Threat Estimation, (2) Perfectionism/Certainty, and (3) Importance/Control of 
thoughts. The scales have excellent internal consistency (α>.89 for each subscale), and the 
total score on the OBQ-44 distinguishes between people diagnosed with OCD and non-OCD 
anxious controls (OCCWG, 2005). 
2.5.5 Attrition 
 Attrition was defined as the number of participants dropping out of the study for each 
study arm and at each time point.    
2.6 Stop/go Criteria 
 In order to proceed to a definitive trial, the between-group post-intervention 
difference on the YBOCS-II would need to be greater than 0 in favour of MB-ERP and the 
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95% CI for this effect would need to include the minimum clinically important difference 
(MCID) of 5 points. 
2.7 Sample size 
 The sample size for this study was based on the recommended minimum of 12 
completer participants per arm for a pilot RCT (Julious, 2005). We aimed to recruit 
approximately 20 people per arm to conservatively allow for up to 40% attrition. 
2.8 Randomisation and Blinding  
 To conceal allocation from the research team, an online randomisation system was 
set up by the independent Clinical Trials Unit (CTU) using 1:1 allocation to either an ERP 
group or a MB-ERP group using blocks of size two. The CTU were blind to participant 
details. A research assistant enrolled participants and assigned them to interventions through 
the CTU online system. The first and second set of groups took place in the two sites seven 
months apart. Post-therapy and six-month follow-up assessments were completed by a 
research assistant blind to treatment allocation. Breaches to research assistant blinding were 
addressed by recruiting another blinded research assistant to conduct the assessment. All 
participants were blind to study hypotheses.  
2.9 Data & Safety Monitoring 
   During the study three Trial Steering Committee meetings were held to discuss the 
study’s progress and report any adverse events. Data quality assurance was overseen by the 
trial statistician who co-ordinated a data checking process where 16% of the study data was 
re-entered by a research assistant external to the study and then checked for inconsistencies.  
2.10 Data analysis 
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 In line with the advice and guidance in the literature for evaluating pilot RCTs we 
did not carry out any hypothesis tests because the study was not intended or powered to 
detect statistically significant effects (Leon, Davis, & Kraemer, 2011). In pilot trials the 
guidance is only to report descriptive statistics (Lee, Whitehead, Jacques, & Julious, 2014). 
We report descriptive statistics for all participant characteristics and clinical outcomes in the 
form of counts, proportions, means, standard deviations and ranges as appropriate. Analysis 
was carried out on an intention-to-treat principle so all participant data was analysed 
according to their randomisation allocation.  We were also interested in estimating treatment 
effects to look for an indication of potential superiority of the MB-ERP over ERP treatment 
on the primary outcome. Treatment effects were calculated at both post-therapy and the six-
month follow-up time points separately using Linear Regression with the clinical measure as 
the outcome. Treatment group (ERP or MB-ERP) was entered into the regression as a factor 
and baseline clinical measures were entered as covariates. Corresponding 95% confidence 
intervals were calculated for all treatment effects. As the analysis was exploratory, no 
corrections were made for missing data in the analysis. Cohen’s d was calculated from the 
unstandardized estimate of the between group difference divided by the pooled baseline 
standard deviation. 
3. Results 
3.1 Participant and Study Characteristics 
FIGURE 1 HERE 
TABLE 1 HERE 
 The consort diagram (Figure 1) shows the trial profile. In total, 37 participants were 
randomised to an MB-ERP (n=19) or ERP (n=18) group. One person was screened out due to 
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meeting exclusion criteria. Participant characteristics are shown in Table 1. All baseline 
participant characteristics were similar between groups.  
Study retention was good at post-therapy: 86% of participants were followed up post-
therapy and drop-outs totalled 1 (5.6%) participant in the ERP group and 4 (21%) in the MB-
ERP group.  The 6-months follow-up rate of 65% was below target; 6 (33%) participants 
dropped out from the ERP group and 7 (37%) from MB-ERP. 
Data completeness for participants retained in the study was 97% at post-therapy and 
87% at follow-up. The lower level of data completeness at follow-up was due to 3 (13%) 
participants providing incomplete scores on parts of the OBQ. On the primary outcome, data 
was only missing due to non-collection for 1 (4%) participant at follow-up.   
Homework data collection was poor with 72% and 55% of weekly ERP homework 
diaries missing in the ERP and MB-ERP groups, respectively. In addition, 63% of the 
mindfulness diaries were missing in the MB-ERP group. 
3.2 Main Outcomes 
3.2.1 OCD Symptom Severity 
 TABLE 2 HERE 
 Table 2 shows the distribution of clinical outcomes by study arm by time point. At 
baseline, the distribution of YBOCS-II was similar in the two study arms with a mean of 29.1 
(SD 6; range 19-40) in the MB-ERP group and 29.8 (SD 7.6; range 13-46) in the ERP group. 
Any between-group differences for all clinical outcomes were negligible at baseline. 
 The post-therapy distributions of the YBOCS-II indicated mean pre-post therapy 
change in both study arms of 6.1 points in the MB-ERP arm and 9.1 points in ERP which 
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increased from pre-therapy to six-month follow-up:10.8 points in the MB-ERP arm and 11.3 
points in the ERP arm. 
 TABLE 3 HERE 
 Table 3 shows estimated effect sizes for each clinical outcome by time point. At 
post-intervention, the between-group difference was 2.4 YBOCS-II points (95% CI -3.8 to 
8.6) with a corresponding Cohen’s d of 0.36 (95% CI -0.37,1.08) in favour of ERP. At 6-
months follow-up the between-group difference was 0.3 YBOCS-II points in favour of MB-
ERP (95% CI -11.4 to 10.8), Cohen’s d = -0.04 (95% CI -0.9,0.8), suggesting negligible 
between-group differences. The 95% confidence interval at post-intervention excludes the 
minimum clinically importance difference (MCID) of a five point between-group difference 
on the YBOCS-II.  
3.2.2 Engagement  
 A mean of 6.5 sessions (SD 3.4; range 0-10) out of 10 were attended with little 
difference between the two groups: MB-ERP had a mean session attendance of 6.6 (SD 3.4; 
range 1-10) and ERP had 6.4 (SD 3.4; range 0-10). The average number of ERP tasks per 
week was 20 in the ERP group and 16 in the MB-ERP group. On average five formal 
mindfulness practices were reported each week by participants in the MB-ERP arm. 
3.2.3 Therapy Fidelity 
 Therapist fidelity to the ERP and MB-ERP protocols were high at 90% and 93% 
respectively. 
3.2.4 Secondary outcomes 
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 Following treatment, participants in the MB-ERP condition showed greater levels of 
mindfulness on all subscales of the FFMQ compared to ERP. Between-group differences on 
FFMQ total was 6.0 points at post-intervention (95% CI -1.4,13.4), a medium effect (Cohen’s 
d=0.53) and 7.9 points at 6-months follow-up (95% CI -1.6, 17.4), a large effect (Cohen’s 
d=0.70). As shown in Table 3, summary estimates of the other secondary outcomes of 
wellbeing (SWEMWS) depression (BDI-II) and OCD-related beliefs (OBQ-44) showed 
negligible, small or medium between-group effect sizes that were mostly but not all in favour 
of the ERP group compared to MB-ERP.  
 3.2.5 Adverse events and serious adverse events 
No adverse events were reported.  
4. Discussion 
 This was an internal pilot RCT of MB-ERP compared to standard ERP groups not 
intended and underpowered to detect statistically significant effects. However, the 95% 
confidence intervals for between-group difference in improvements in OCD symptom 
severity at post-intervention did not include the minimum clinically important difference 
(MCID) on OCD symptom severity. This means that a definitive trial of the same design 
would be very unlikely to find that MB-ERP leads to clinically important improvements in 
OCD symptom severity in comparison to ERP alone. In addition, there were negligible 
between-group differences on measures of therapy engagement (session attendance and 
homework task completion). 
 The study also failed to support the suggestion that the MB-ERP protocol has 
potential to lead to greater improvements in OCD-related beliefs, depression or wellbeing 
than ERP alone either at post-therapy or at six-months follow-up. Although the study was 
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underpowered to detect statistically significant differences, it is notable that almost all post-
intervention and follow-up scores on the measures of depression, wellbeing and OCD-related 
beliefs were numerically in favour of ERP in comparison to MB-ERP. Given that the 
strongest evidence for MBIs in the context of mental health is in the treatment of depression 
(Kuyken et al., 2016; Strauss et al., 2014) this may seem somewhat surprising. However, 
MBIs may not be more effective in the treatment of depression when compared to alternative 
psychological interventions with equivalent therapist contact time (Farb et al., 2018) and 
therefore the findings in the current study are perhaps not so surprising. However, there was 
evidence that MB-ERP has the potential to improve mindfulness in comparison to ERP as 
between-group differences were in favour in MB-ERP at both post-therapy and follow-up, 
with medium to large effect sizes.  
4.1 Findings in Context 
 This study was based on the theoretical reasons proposed for why cultivating 
mindfulness might benefit outcomes for ERP for OCD (Strauss, Rosten, et al., 2015). First, 
MB-ERP with its teacher-led experiential mindfulness practice was expected to enable people 
to accept intrusive thoughts elicited during ERP tasks and to remain engaged with the task. 
Second, it was expected, that teacher-guided mindfulness practice would enable people to 
fully attend to and accept physical sensations of anxiety that occur during ERP and, therefore, 
to remain fully engaged with the tasks. Third, because mindfulness practice places emphasis 
on bringing awareness to behavioural choices, MB-ERP was expected to enable people to 
recognise urges to engage in compulsive behaviours and choose to resist them. Findings from 
this study do not support these suggestions. 
 It could be argued that insufficient opportunity for participants to cultivate 
mindfulness in the MB-ERP groups, may explain the lack of apparent effects on OCD 
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symptom severity. Indeed, time devoted to mindfulness practice and discussion in each 
session was considerably less than in MBCT. Only 30 minutes were devoted to mindfulness 
practice and discussion in each MB-ERP session (five hours in total). This is far less than in 
MBCT, where the majority of 16-20 therapy hours is spent practicing mindfulness and 
discussing learning from mindfulness practice (Segal et al., 2013). In addition, mindfulness 
practices in MB-ERP were shorter (15 minutes maximum) than in MBCT (30 minutes 
maximum). Therefore, there was perhaps simply insufficient attention given to cultivating 
mindfulness in the current study.  
 Whilst these caveats are important to note, the between-group improvements in 
mindfulness for MB-ERP compared to ERP are of interest. Despite a reduced focus and time 
spent on mindfulness practice and discussion compared to MBCT, between-group differences 
in improvements in mindfulness were in the medium range at post-therapy (d=0.53) and large 
range at six-months follow-up (d=0.70). These between-group effect sizes on self-reported 
mindfulness compare favourably with a meta-analysis of RCTs of MBIs that reported a 
medium between-group effect on mindfulness (Hedges g=0.47) (Visted, Vøllestad, Nielsen, 
& Nielsen, 2015) and with findings that MBIs with brief mindfulness practices can be of 
clinical benefit (Strauss, Luke, Hayward, & Jones, 2015). This suggests, (with the caveat that 
this is a pilot trial) that MB-ERP compared to ERP has the potential to improve mindfulness 
whilst not improving OCD symptom severity or mechanisms of OCD-related beliefs. This 
challenges the theoretical notion that improving mindfulness should improve OCD symptoms 
by enabling non-judgemental acceptance of intrusive thoughts, non-judgemental acceptance 
of bodily sensations of anxiety and greater choice in responding to compulsive urges (Strauss 
et al., 2015). 
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 On average, participants attended 6.5 of the ten group sessions, with little difference 
in this rate between treatment arms. In order to maximise engagement with each intervention, 
and in line with the treatment protocols, if a participant missed a session they were contacted 
by phone by one of the group facilitators immediately after the session to explore reasons for 
missing the session and to identify and plan daily ERP tasks. In the MB-ERP arm this also 
included an exploration of experiences of home mindfulness practice and an encouragement 
to continue with mindfulness practice at home. In future studies further efforts to improve 
session attendance should be included such as holding groups in venues that minimise the 
need for participant travel. 
4.2 Strengths and Limitations 
 Strengths of this study include its design. Randomisation was conducted 
independently and post-therapy assessments were conducted blind to allocation. Moreover, 
and unusually for a study of psychological therapy, participants were blind to study 
hypotheses, thus reducing a common potential source of bias. The trial protocol ensures 
transparency in publication. 
 Limitations of this study also pertain to its design. This is a pilot study, 
underpowered to detect statistically significant effects and liable to biases inherent in small 
sample sized studies. Despite this, it is possible to draw conclusions about the primary 
hypotheses as the 95% confidence intervals for the between-group effect on OCD symptom 
severity at post-intervention did not include the MCID. This means, that a definitive trial 
would be highly unlikely to find that MB-ERP is more effective than ERP at improving OCD 
symptom severity. The design however does mean that we need to be cautious in over-
interpreting findings on other outcomes where confidence intervals are wide and cross zero. 
Another limitation is that no formal measure of intervention acceptability was included. 
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Whist rates of intervention engagement were similar between the two treatment arms, which 
could be taken as a proxy indicator of intervention acceptability, future research should 
include a formal measure. A further limitation was that participants in the ERP arm of the 
study received more therapist-assistant ERP time than MB-ERP participants as a proportion 
of each MB-ERP session was devoted to mindfulness practice and inquiry. Whilst the 
addition of mindfulness practice and inquiry was explicitly to improve engagement with 
ERP, the reduced time spent on ERP tasks may have contributed to the findings. Finally, 
study retention at follow-up was 65%, lower than expected. It is possible that this has led to a 
biased account of effects at follow-up if retained participants were those who had better 
outcomes. Future studies should include methods for improving study retention including 
maintaining contact with participants during the follow-up period, paying participants for 
their time to complete assessments and having the option to complete assessments online and 
so avoid the need for participants to travel.  
4.3 Clinical Implications 
 In the context of a proliferation in interest in mindfulness, evidence from our study 
suggests that adding mindfulness to ERP (at least in the way it was done in this study) may 
not improve symptom severity compared to ERP alone. Findings suggest that whilst MBIs 
may have much to offer people experiencing a range of mental health difficulties, we should 
not abandon well-established, well-evidenced interventions. In short, we recommend that 
current guidelines for OCD are followed; that people with OCD are given access to ERP with 
or without cognitive therapy (American Psychiatric Association, 2007; National Institute of 
Health and Care Excellence [NICE], 2005). This is not to rule out the possibility that MB-
ERP may have benefits over ERP for sub-groups of people with OCD and future qualitative 
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and quantitative research could explore this given the theoretical rationale for adding a 
mindfulness-based approach to ERP. 
4.4 Implications 
 It would be premature to abandon research exploring the potential of learning 
mindfulness for people experiencing OCD based on the findings of this pilot trial for a 
number of reasons. As noted above, the amount of time devoted to mindfulness practice and 
discussion was much reduced compared to well-established interventions such as MBCT. 
Although the point estimate on between-group differences in mindfulness suggested that MB-
ERP can lead to improvements in mindfulness relative to ERP, the 95% confidence interval 
for this effect crossed zero meaning that this point estimate must be treated cautiously. Future 
research should examine the effects of cultivating mindfulness for OCD using a more 
intensive approach, perhaps based on the well-established MBCT protocol, but adapting this 
for OCD.  In addition, whilst speculative, it may be the case that ERP and MB-ERP are 
effective for different groups of people with OCD. Whilst the current study does not allow an 
exploration of participant moderators of outcome, qualitative research of MB-ERP may help 
to elucidate if this intervention has greater potential for subgroups of people with OCD in 
comparison to ERP. Finally, therapy format (group versus individual) may have a bearing on 
effectiveness. Whilst group ERP is recommended for OCD (National Institute of Health and 
Care Excellence [NICE], 2005), an individual approach has potential advantages in terms of 
more closely tailoring the treatment plan to the participant, more closely monitoring 
participant progress and facilitating disclosure of shame-related OCD thoughts and beliefs. 
Future research could explore the potential of MB-ERP delivered in individual format where 
such factors could be attended to.  
4.5 Conclusions 
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 Although underpowered to draw definitive conclusions, findings from this pilot RCT 
suggest that adding a brief mindfulness-based intervention to ERP may not lead to clinically 
meaningful improvements in OCD symptom severity outcomes compared to ERP alone. 
Furthermore, findings suggest that improvements in mindfulness may not translate into 
improvements in OCD symptom severity. Clinical implications are to underline the 
importance of adhering to current treatment guidelines and to continue to offer ERP to people 
with OCD. Further research is now needed to investigate if a greater focus on cultivating 
mindfulness and decoupling learning mindfulness from an explicit focus ERP has potential, 
in addition to exploring participant-level moderators of therapy outcome (i.e. that different 
approaches may lead to better outcomes for different people). It is important not to abandon 
work in this area based on findings from the current pilot study, particularly given the sound 
theoretical reasons why cultivating mindfulness might have much to offer people struggling 
with OCD. 
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Table 1 Descriptive summary of participant characteristics  
 
 MB-ERP 
N=19 
 ERP 
N=18 
 
Gender     
Female 15 79% 9 50% 
Male  4 21% 9 50% 
Age median years (range) 33 (21-49) 27 (18-51) 
Ethnicity     
White British 18 95% 18 100% 
Black & Minority Ethnic 1 5% 0 0% 
Site     
Site 1 10 53% 9 50% 
Site 2 9 47% 9 50% 
Employment Status     
Employed 12 63% 10 56% 
Unemployed 4 21% 6 33% 
Other  3 16% 2 11% 
Education Level     
Left school before 16 4 21% 0 0% 
Left school at 16 5 26% 3 17% 
Left school at 17/18 1 5% 0 0% 
Completing/completed College 4 21% 6 33% 
Completing/completed 
University 5 26% 9 50% 
Marriage Status     
30 
 
single 12 63% 11 61% 
married/civil 
partnership 4 21% 3 17% 
cohabiting 3 16% 3 17% 
separated/divorced 0 0% 1 6% 
 
Values are numbers (percentages) unless otherwise indicated. 
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Table 2 Descriptive statistics of clinical outcomes by study arm and time point 
 
 
 Study Arm 
 Measure MB-ERP  ERP 
  N Mean (SD)  N Mean (SD) 
Baseline YBOCS II 19 29.11 (6.02) 18 29.83 (7.59) 
T1  15 22.93 (8.15)  17 21.12 (9.78) 
T2  11 17.27 (13.57)  12 18.17 (11.82) 
       
Baseline SWEMWBS 19 17.84 (3.98) 
 
18 18.89 (4.70) 
T1  15 19.33 (5.42)  17 20.29 (4.24) 
T2  11 22.00 (5.81)  12 21.50 (5.37) 
       
Baseline BDI-II 19 25.68 (10.04)  18 25.39 (14.46) 
T1  15 22.40 (14.81)  17 16.82 (12.26) 
T2  12 17.08 (12.56)  11 17.18 (14.70) 
       
FFMQ-SF       
Baseline TOTAL 19 63.05 (9.97) 
 
18 63.1 (12.77) 
T1  15 74.73 (10.55)  17 69.82 (12.87) 
T2  11 79.00 (11.61)  12 72.75 (15.90) 
       
Baseline Observing 19 12.47 (3.04) 
 
18 11.39 (4.33) 
T1  15 13.07 (3.24)  17 10.59 (4.98) 
T2  12 14.00 (3.16)  12 12.67 (4.92) 
       
Baseline Describing 19 15.21 (3.36) 
 
18 14.83 (4.45) 
T1  15 16.20 (3.41)  17 16.18 (4.32) 
T2  12 17.00 (2.63)  12 17.17 (4.76) 
       
Baseline Acting with Awareness 19 12.74 (4.29) 
 
18 14.44 (4.55) 
T1  15 15.33 (3.90)  17 15.94 (4.66) 
T2  12 15.92 (3.68)  12 15.75 (5.10) 
       
Baseline Non-judging 19 11.00 (2.49) 
 
18 12.67 (3.43) 
T1  15 15.53 (3.74)  17 14.29 (3.95) 
T2  11 15.64 (5.03)  12 13.92 (4.62) 
       
Baseline Non-reacting 19 11.63 (2.45) 
 
18 10.28 (3.23) 
T1  15 14.60 (4.12)  17 12.82 (3.56) 
T2  12 15.67 (4.60)  12 13.25 (4.41) 
       
OBQ-44       
Baseline Total 19 201.58 (35.35) 
 
18 201.39 (48.85) 
T1  14 174.39 (53.01)  16 157.16 (48.18) 
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T2  9 166.44 (59.25)  12 159.83 (38.97) 
       
Baseline Responsibility/Threat 
estimation 
19 78.32 (21.20) 
 
18 77.94 (19.39) 
T1  15 68.43 (23.50)  16 63.75 (21.21) 
T2  10 66.90 (24.94)  12 63.25 (23.35) 
       
Baseline Perfectionism/Certainty 19 82.63 (16.16) 
 
18 72.78 (25.08) 
T1  15    72.93 (21.01)  16 55.03 (23.85) 
T2  11 69.36 (22.73)  12 62.17 (20.67) 
       
Baseline Importance/Control of 
thoughts 
19 40.63 (13.36) 
 
18 50.67 (16.13) 
T1  15 36.20 (16.41) 
 
16 38.38 (14.52) 
T2  12 38.50 (22.81) 
 
12 34.42 (12.66) 
 
Note: Exposure Response Prevention (ERP), Mindfulness Based -Exposure Response Prevention MB-
ERP; Yale-Brown Obsessive Compulsive Scale Second Edition (YBOCS II), Short Warwick-
Edinburgh Mental Well-being Scale (SWEMWB), Five Facets of Mindfulness Questionnaire – short 
form (FFMQ-SF), Beck Depression Inventory – second edition (BDI-II), Obsessional Beliefs 
Questionnaire – 44 item version (OBQ-44); Standard Deviation (SD); Post therapy (T1), 6 months 
follow-up (T2) 
  
33 
 
Table 3 Unstandardised and standardised between-group effect sizes at post treatment and at follow-up 
  Unstandardised effects  
Standardised between-group 
effects 
Clinical Measure 
Time 
point 
Effect 
size 
95% CI for 
effect size 
Standard 
Error 
p-value Cohen's  
d* 
95% CI for 
Cohen's d 
YBOCS-II  T1 2.40 (-3.77,8.57) 3.02 0.43  0.36 (-0.37,1.08) 
 T2 -0.29 (-11.39,10.82) 5.32 0.96  -0.04 (-0.90,0.81) 
SWEMWS  T1 -0.39 (-3.19,2.41) 1.37 0.78  -0.09 (-0.81,0.63) 
 T2 1.22 (-2.28,4.72) 1.68 0.48  0.28 (-0.58,1.14) 
BDI-II T1 4.74 (-2.36,11.83) 3.47 0.18  0.39 (-0.34,1.11) 
 T2 0.80 (-7.56,9.16) 4.01 0.84  0.07 (-0.79,0.92) 
FFMQ-SF    
     
TOTAL T1 5.99 (-1.6,17.44) 3.61 0.11  0.53 (-0.20,1.26) 
 T2 7.92 (-1.6,17.4) 4.56 0.10  0.70 (-0.18,1.59) 
Observing T1 1.65 (-0.32,3.61) 0.96 0.10  0.44 (-0.28,1.17) 
 T2 1.16 (-1.87,4.2) 1.46 0.43  0.31 (-0.53,1.16) 
Describing T1 0.37 (-1.99,2.72) 1.15 0.75  0.09 (-0.62,0.81) 
 T2 0.83 (-1.39,3.05) 1.07 0.45  0.21 (-0.63,1.05) 
Acting with Awareness T1 0.55 (-1.91,3.02) 1.21 0.65  0.12 (-0.59,0.84) 
 T2 1.26 (-1.48,3.99) 1.31 0.35  0.28 (-0.56,1.12) 
Non-Judging T1 1.91 (-0.99,4.81) 1.42 0.19  0.62 (-0.11,1.36) 
 T2 2.32 (-1.95,6.59) 2.05 0.27  0.76 (-0.13,1.64) 
Non-reacting T1 1.14 (-1.64,3.92) 1.36 0.41  0.39 (-0.33,1.12) 
 T2 1.58 (-1.68,4.85) 1.57 0.321  0.55 (-0.31,1.40) 
OBQ-44    
     
Total T1 11.53 (-23.22,46.28) 16.94 0.501  0.28 (-0.47,1.02) 
 T2 6.96 (-34.46,48.38) 19.72 0.73  0.17 (-0.74,1.07) 
Responsibility/Threat Estimation T1 0.83 (-13.77,15.44) 7.13 0.91  0.04 (-0.69,0.77) 
 T2 -3.05 (-22.37,16.27) 9.23 0.75  -0.15 (-1.03,0.73) 
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Perfectionism/Certainty T1 9.09 (-4.61,22.78) 6.69 0.19  0.43 (-0.31,1.16) 
 T2 2.46 (-13.16,18.08) 7.49 0.75  0.12 (-0.74,0.97) 
Importance/Control of thoughts T1 1.87 (-9.16,12.9) 5.39 0.73  0.12 (-0.61,0.85) 
  T2 8.86 (-7.12,24.84) 7.68 0.26  0.57 (-0.28,1.43) 
 
Note: Yale-Brown Obsessive Compulsive Scale Second Edition (YBOCS-II), Short Warwick-Edinburgh Mental Well-being Scale (SWEMWB), Beck 
Depression Inventory – second edition (BDI-II), Five Facets of Mindfulness Questionnaire – short form (FFMQ-SF), Obsessional Beliefs Questionnaire – 
44 item version (OBQ-44); Standard Deviation (SD); Post therapy (T1), 6 months follow-up (T2); Confidence interval (CI) 
* In interpreting the direction of effects, a negative Cohen’s d would show that outcomes numerically favour MB-ERP in comparison to ERP for the 
following measures: Y-BOCS-II, BDI-II and OBQ-44. A positive Cohen’s d would show that outcomes numerically favour MB-ERP in comparison to 
ERP for SWEMWS and FFMQ-SF scores.  
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Figure 1: CONSORT Diagram showing participant flow through the study 
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